Abstract

The possibility of replacing the originally discovered and widely used DNA reprogramming transcription factors is stimulating enormous effort to identify more effective compounds that would not alter the genetic information. Here, we describe the generation of induced pluripotent stem cells (iPSc) from head-derived primary culture of mouse embryonic cells using small chemical inhibitors of the MEK and TGF-beta pathways without delivery of exogenous transcription factors. These iPSc express standard pluripotency markers and retain their potential to differentiate into cells of all germ layers. Our data indicate that head-derived embryonic neural cells might have the reprogramming potential while neither the same primary cells cultivated over five passages in vitro nor a cell population derived from adult brain possesses this capacity. Our results reveal the potential for small molecules to functionally replace routinely used transcription factors and lift the veil on molecular regulation controlling pluripotency. The conditions described here could provide a platform upon which other genome non integrative and safer reprogramming processes could be developed. This work also shows novel potential for developing embryonic neural cells.

Highlights

  • A majority of techniques routinely used for reprogramming induced pluripotent stem cells utilize direct delivery of selected transcription factors (TFs)

  • In order to test whether chemical inhibitors of TGF-beta and MEK signaling pathways are sufficient for reprogramming towards pluripotency, primary cell culture from CF-1 mouse embryo at 12.5 days post coitum (DPC) was treated repeatedly within 5 d with chemical inhibitors of MEK (PD0325901; 0.5 μM) and TGF-beta (SB431542; 2 μM) (See Fig 1A and Materials and Methods section for details)

  • In contrast to Oct4, we detected no significant increase of Nanog expression after treatment with inhibitors

Read more

Summary

Introduction

A majority of techniques routinely used for reprogramming induced pluripotent stem cells (iPSc) utilize direct delivery of selected transcription factors (TFs). Current reprogramming methods are mostly based on delivery of reprogramming TFs in the form of exogenous DNA. Other methods use mRNA forms of TFs [7,8], micro-RNAs [9,10], or purified recombinant TFs with the help of other enhancers like valproic acid [11,12]. Some reprogramming TFs can be dispensed with due to those cells’ relatively high endogenous expression levels [13,14] or these can be substituted by other components [15,16]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call